Recent Updates
Recently added Catalysts
BFRG Positive Sentiment Score: 65/100

BullFrog AI Files Quarterly Report on Form 10-Q Gaithersburg, MD

Key Takeaway: BullFrog AI Holdings, Inc. filed its Quarterly Report on Form 10-Q with the SEC for the quarter ended March 31, 2023, and has resolved prior non-compliance issues with Nasdaq regulations. The company is focusing on leveraging its proprietary bfLEAP AI platform to enhance precision medicine by predicting patient responses to therapies. Despite achieving compliance, the company faces uncertainties regarding future performance and competition in the evolving digital health landscape.

Market Sentiment Analysis

POSITIVE FACTORS

  • BullFrog AI is now compliant with Nasdaq Listing Rule 5250(c)(1).
  • The company is leveraging its bfLEAP AI platform to streamline therapeutics development.
  • Collaborations with leading institutions like Johns Hopkins University bolster their position in AI-driven drug development.

CONCERNS & RISKS

  • The company was previously not in compliance with Nasdaq's periodic filing requirements.
  • There is uncertainty surrounding future performance projections and market competition.

Full Press Release Details

BullFrog AI Files Quarterly Report on Form 10-Q
Gaithersburg, MD - May 26, 2023 - BullFrog
AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine
learning to usher in a new era of precision medicine, today announced it filed its Form 10-Q with the Securities and Exchange Commission
("SEC") for the quarter ended March 31, 2023.
BullFrog AI received notice from Nasdaq on May 23,
2023, notifying the Company that it was not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq
Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2023 was not filed with
the Securities and Exchange Commission by the required due date. The Company is now in compliance with Nasdaq Listing Rule 5250(c)(1).
BullFrog AI is a digital technology company using
machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including
Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP artificial
intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients
will respond to therapies in development. BullFrog AI is deploying bfLEAP for use at several critical stages of development with
the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure
rates for new therapeutics, and impacting the lives of countless patients that may seek to receive the therapies they need.
For more information visit BullFrogAI at
Safe Harbor Statement
This press release contains forward-looking statements.
We base these forward-looking statements on our expectations and projections about future events, which we derive from the information
currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial
performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking
statements by those that are not historical in nature, particularly those that use terminology such as "may," "should,"
"expects," "anticipates," "contemplates," "estimates," "believes," "plans,"
"projected," "predicts," "potential," or "hopes" or the negative of these or similar terms.
In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of
the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business.
These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements
are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or
our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions
about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions,
the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might
RedChip Companies, Inc.
SOURCE: BullFrog AI Holdings, Inc.

Frequently Asked Questions

What is BullFrog AI's primary focus?

BullFrog AI focuses on using machine learning to advance precision medicine.

When was BullFrog AI's quarterly report filed?

BullFrog AI filed its quarterly report on May 26, 2023.

What issue did BullFrog AI encounter with Nasdaq?

BullFrog AI was initially non-compliant with Nasdaq's filing requirements.

What is the bfLEAP platform used for?

The bfLEAP platform predicts patient responses to developing therapies.

Who does BullFrog AI collaborate with?

BullFrog AI collaborates with top research institutions, including Johns Hopkins.

Last updated: May 26, 2023